Microproteinuria and Long-term Prognosis with Respect to Renal Function and Survival in Normotensive and Hypertensive Women: A 24-year Follow-up of a Representative Population Sample of Women in Gothenburg, Sweden

References

• Bulpitt CJ, Beilin LJ, Clifton P, Coles EC, Dollery CT, Gear JS, et al. Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hyper-tension Care Computing Project. Lancet 1979; ii: 134–7.
   Google Scholar
• Kannel WB, Stampfer MJ, Castelli WP, Verter J. The prognostic significance of proteinuria: the Framingham study. Am Heart J 1984; 108: 1347–52.
   PubMed Web of Science ®Google Scholar
• Samuelsson 0, Wilhelmsen L, Elmfeldt D, Pennert K, Wedel H, Wikstrand J, et al. Predictors of cardiovascular morbidity in treated hypertension: results from the Primary Preventive Trial in Goteborg, Sweden. J Hy-pertens 1985; 3: 167–76.
   Google Scholar
• Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; i: 1430–2.
   Google Scholar
• Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988; ii: 530–3.
   Google Scholar
• Cerasola G, Cottone S, D'Ignoto G, Grasso L, Mangano MT, Carapelle E, et al. Micro-albuminuria as a predictor of cardiovascular damage in essential hypertension. J Hypertens 1989; 7 (Suppl 6): S332–3.
   Google Scholar
• Agewall S, Persson B, Samuelsson 0, Ljungman S, Herlitz H, Fagerberg B, on behalf of The Risk Factor Intervention Study Group. Microalbuminuria in treated hypertensive men at high risk of coronary disease. J Hypertens 1993; 11: 461–9.
   Google Scholar
• Ljungman S, Wikstrand J, Hartford M, Berglund G. Urinary albumin excretion-a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens 1996; 9: 770–8.
   Google Scholar
• Perera GA. Hypertensive vascular disease; description and natural history. J Chron Dis 1955; 1: 33–42.
   PubMedGoogle Scholar
• Brunner FP, Selwood NH, on behalf of the EDTA Registration Committee. Profile of patients on RTT in Europe and death rates due to major causes of death. Kidney Int 1992; 38 (Suppl): S4–15.
   Google Scholar
• Excerpts from the United States Renal Data System 1998 Annual Data Report. II. Incidence and prevalence of ESRD. Am J Kidney Dis 1998; 32 (Suppl 1): S38–49.
   PubMedGoogle Scholar
• Siewert-Delle A, Ljungman S, Andersson OK, Wilhelm-sen L. Does treated primary hypertension lead to end-stage renal disease? A 20-year follow-up of the Primary Prevention Study in Goteborg, Sweden. Nephrol Dial Transplant 1998; 13: 3084–90.
   Google Scholar
• Bengtsson C, Blohmé G, Hallberg L, Hällstrom T, Isaksson B, Korsan-Bengtsen K, et al. The Study of Women in Gothenburg 1968-69-a population study. General design, purpose and sampling results. Acta Med Scand 1973; 193: 311–8.
   PubMedGoogle Scholar
• Bengtsson C, Ahlqwist M, Andersson K, Björkelund C, Lissner L, Söderström M. The Prospective Population Study of Women in Gothenburg, Sweden 1968-69 to 1992-93. A 24-year follow-up study with special reference to participation, representativeness, and mor-tality. Scand J Prim Health Care 1997; 15: 214–9.
   Google Scholar
• Piscator M. Proteinuria in chronic cadmium poisoning. Arch Environ Health 1962; 5: 325–32.
   PubMed Web of Science ®Google Scholar
• Mantel N. Chi-square tests with one degree of freedom; extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963; 8: 690–700.
   Google Scholar
• Damsgaard EM, Froland A, Jörgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortal-ity in elderly people. Br Med J 1990; 300: 297–300.
   Google Scholar
• Agewall S, Wikstrand J, Ljungman S, Fagerberg B, on behalf of the Risk Factor Intervention Group. Usefulness of microalbuminuria in predicting cardiovascular mor-tality in treated hypertensive men with and without diabetes mellitus. Am J Cardiol 1997; 80: 164–9.
   Google Scholar
• Newman DJ, Thakkar H, Medcalf EA, Gray MR, Price CP. Use of urine albumin measurement as a replacement for total protein. Clin Nephrol 1995; 43: 104–9.
   Google Scholar
• Yudkin JS. Microalbuminuria: a genetic link between diabetes and cardiovascular disease. Ann Med 1992; 24: 517–22.
   PubMed Web of Science ®Google Scholar
• Haffner SM, Stern MP, Kozlowski Gruber K, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 1990; 10: 727–31.
   Google Scholar
• Redon J, Liao Y, Lozano JV, Miralles A, Pascual JM, Cooper RS. Ambulatory blood pressure and microalbu-minuria in essential hypertension: role of circadian variability. J Hypertens 1994; 12: 947–53.
   PubMed Web of Science ®Google Scholar
• James MA, Fotherby MD, Potter JF. Microalbuminuria in elderly hypertensives: reproducibility and relation to clinic and ambulatory blood pressure. J Hypertens 1994; 12: 309–14.
   Google Scholar
• Parving H-H, Jensen WE, Mogensen CE, Evrin P-E. Increased urinary albumin-excretion rate in benign essential hypertension. Lancet 1974; i: 1190–2.
   Google Scholar
• Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308–15.
   PubMed Web of Science ®Google Scholar
• Metcalf P, Baker J, Scott A, Wild C, Scragg R, Dryson E. Albuminuria in people at least 40 years old: effect of obesity, hypertension and hyperlipidemia. Clin Chem 1992; 38: 1802–8.
   PubMed Web of Science ®Google Scholar
• Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Clausen P, Appleyard M, Jensen G. Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive indivi-duals. J Hum Hypertens 1997; 11: 727–32.
   Google Scholar
• Ruilope LM. Microalbuminuria as risk in essential hypertension. Nephrol Dial Transplant 1997; 12 (Suppl 2): 2–5.
   PubMedGoogle Scholar
• Nilsson T, Svensson A, Lapidus L, Lindstedt G, Nystrom E, Eggertsen R. The relations of microalbuminuria to ambulatory blood pressure and myocardial wall thick-ness in a population. J Intern Med 1998; 244: 55–9.
   PubMed Web of Science ®Google Scholar
• Bianchi S, Bigazzi R, Valtriani C, Chiapponi I, Sgherri G, Baldari G, et al. Elevated serum insulin levels in patients with essential hypertension and microalbumi-nuria. Hypertension 1994; 23: 681–7.
   PubMed Web of Science ®Google Scholar
• Agewall S, Fagerberg B, Attvall S, Ljungman S, Urbanavicius V, Tengborn L, et al. Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. J Intern Med 1995; 237: 195–203.
   PubMed Web of Science ®Google Scholar
• Zavaroni I, Bonini L, Gasparaini P, Zuccarelli A, Dall'Aglio E, Barilli L, et al. Dissociation between urinary albumin excretion and variables associated with insulin resistance in a healthy population. J Intern Med 1996; 240: 151–6.
   Google Scholar
• Kilaru P, Bakris GL. Microalbuminuria and progressive renal disease. J Hum Hypertens 1994; 8: 809–17.
   PubMed Web of Science ®Google Scholar
• Pedrinelli R, Giampietro 0, Carmassi F, Melillo E, Dell'Omo G, Catapano G, et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14–8.
   Google Scholar
• Agrawal B, Berger A, Wolf K, Luft FC. Microalbumi-nuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 1996; 14: 223–8.
   PubMed Web of Science ®Google Scholar